Rational design 2.0: transitioning from static structural biology to computational prioritization and iterative vaccine optimization for RSV - Top-Institutions - MDSpire

Rational design 2.0: transitioning from static structural biology to computational prioritization and iterative vaccine optimization for RSV

By
Xiulong Wei
Jing Chen
Zhaolong Li
June 22, 2026
0 min

Frontiers In Immunology

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

#1

NIAID Vaccine Research Center (VRC), National Institutes of Health

Bethesda, Maryland
Key Differentiators
- Infectious Disease
- Vaccine Research
#2

The University of Texas at Austin, Department of Molecular Biosciences (McLellan Lab)

Austin, Texas
Key Differentiators
- Infectious Disease
- Molecular Biosciences
#3

Boston Medical Center

Boston, Massachusetts
Key Differentiators
- Infectious Disease
#4

National Institutes of Health

Bethesda, Maryland
Key Differentiators
- Infectious Disease
- Clinical Trials
#5

VACCELERATE Consortium

Various, Europe
Key Differentiators
- Infectious Disease
- Vaccine Trials

Original Source(s)

Frontiers In Immunology

Rational design 2.0: transitioning from static structural biology to computational prioritization and iterative vaccine optimization for RSV

by Xiulong Wei, Jing Chen, Zhaolong Li
June 22, 2026

Related Content

Infection

Global, regional, and national burden of pathogen-attributable infectious diseases in children by age and sex, 1990–2021: a systematic analysis

Jama Network Open

Adjuvanted vs High-Dose Influenza Vaccines in Older US Adults: A Cluster Randomized Crossover Study

Respiratory Care

High-Dose Inhaled Nitric Oxide for Antimicrobial Use: Promise, Caution, and Next Steps

by Autumn Brogan, Vladyslav Dieiev, Ognjen Gajic
June 18, 2026